Adjust Font Sizing:

Parents of Children with Narcolepsy Virtual Support Group

Do you have a child with narcolepsy? Join us on Tuesday, July 13, at 7:00 PM ET/4:00 PM PT for our virtual support group just for parents/caregivers of […]

An Update from the Board of Directors

Dr. Eveline Honig was with Narcolepsy Network for the last 16 years, aiding in its mission to provide education, support, and advocacy for patients and families impacted […]

Virtual Mini-Conferences

Join us for our next free Virtual Mini-Conference, which will be held on Saturday, April 24 at 2:00 PM ET/11:00 AM PT. The theme will be Finding Your […]

Update on the COVID-19 Vaccine

We asked Dr. Michael Thorpy, a member of our Medical Advisory Board from the Sleep-Wake Disorders Center in New York if people with narcolepsy should get the […]

Become a Member for $5! Limited Time Offer!

Join Narcolepsy Network for $5Limited offer now through January 31, 2021 For a limited time, we are lowering our individual annual membership dues to $5. Now is […]

Donate to Make Twice the Impact

Thanks to a few generous donors, if you make a donation before January 1, 2021, they will match your gift up to $10,000. This means your donation […]

Avadel Pharmaceuticals Announces Submission of New Drug Application for FT218 to the FDA

Avadel Pharmaceuticals plc announced the submission of its New Drug Application to the US Food and Drug Administration (FDA) for FT218, an investigational, once-nightly formulation of sodium […]

Mini-Conference Webinar: I Was Just Diagnosed: Now What?

Our second Virtual Mini-Conference webinar was held on December 5. The theme was I Was Just Diagnosed: Now What? and focused on topics for those starting out […]

Support Us on #GivingTuesday

This year has been one to remember! While many of us are still struggling to find a new normal, we are proud of the programs we have […]

Positive Results from IH Phase 3 Study of Xywav

Jazz Pharmaceuticals plc announced positive top-line results from their Phase 3 double-blind, multicenter, placebo-controlled, randomized withdrawal study evaluating the efficacy and safety of an investigational use of […]